IRIS
BALESTRIERI, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 859
NA - Nord America 141
EU - Europa 98
AF - Africa 4
OC - Oceania 3
SA - Sud America 2
Totale 1.107
Salva come PNG Salva come JPEG
Nazione #
SG - Singapore 722
US - Stati Uniti d'America 127
HK - Hong Kong 67
CN - Cina 57
GB - Regno Unito 31
IT - Italia 25
DE - Germania 20
CA - Canada 10
IN - India 7
NL - Olanda 5
MX - Messico 4
UA - Ucraina 4
ZA - Sudafrica 4
AU - Australia 3
FR - Francia 3
AT - Austria 2
CZ - Repubblica Ceca 2
ES - Italia 2
IR - Iran 2
AR - Argentina 1
BD - Bangladesh 1
BR - Brasile 1
FI - Finlandia 1
JP - Giappone 1
LT - Lituania 1
PL - Polonia 1
SI - Slovenia 1
TH - Thailandia 1
TR - Turchia 1
Totale 1.107
Salva come PNG Salva come JPEG
Città #
Hong Kong 67
Singapore 56
Ashburn 35
Boardman 29
Hefei 27
London 27
Shanghai 19
Rome 14
Seattle 6
Toronto 6
Council Bluffs 5
Los Angeles 5
Munich 5
Nuremberg 5
Amsterdam 4
Pune 4
San Francisco 4
Brooklyn 3
Hamburg 3
Markham 3
Paris 3
Boydton 2
Brno 2
Canberra 2
Dallas 2
Guiyang 2
Liverpool 2
Mexico City 2
Santa Clara 2
West Jordan 2
Zapopan 2
Bangkok 1
Bertamirans 1
Boston 1
Burbach 1
Chengdu 1
Chennai 1
Chenzhou 1
Chicago 1
Dhaka 1
Düsseldorf 1
Frankfurt am Main 1
Huntington 1
Jining 1
Johannesburg 1
Lambeth 1
Ljubljana 1
Palo Alto 1
Phoenix 1
Sona 1
São Paulo 1
Turku 1
Venice 1
Volla 1
Warsaw 1
Washington 1
Xingtai 1
Totale 376
Salva come PNG Salva come JPEG
Nome #
Colonic Epithelial Permeability to Ions Is Restored after Vedolizumab Treatment and May Predict Clinical Response in Inflammatory Bowel Disease Patients 193
Novel impedance-pH parameters are associated with proton pump inhibitor response in patients with inconclusive diagnosis of gastro-oesophageal reflux disease according to Lyon Consensus 178
Wall Thickness Ratio—A New Magnetic Resonance Parameter—Is Associated With the Outcome of Biological Therapy in Patients With Ileal and Ileocolonic Crohn’s Disease 96
Mathematical Modeling of Vedolizumab Treatment’s Effect on Microbiota and Intestinal Permeability in Inflammatory Bowel Disease Patients 87
Acid reflux episodes sensitize the esophagus to perception of weakly acidic and mixed reflux in non-erosive reflux disease patients 82
Impedance baseline and reflux perception in responder and non-responder non-erosive reflux disease patients 72
Mechanisms of action of prebiotics and their effects on gastro-intestinal disorders in adults 45
Reflux pattern and role of impedance-pH variables in predicting PPI response in patients with suspected GERD-related chronic cough. 25
The Results From Up-Front Esophageal Testing Predict Proton Pump Inhibitor Response in Patients With Chronic Cough 24
Psychological distress in inflammatory bowel disease 24
Multicenter Validation of the DETAIL Questionnaire for the Screening of Spondyloarthritis in Patients With Inflammatory Bowel Diseases 20
Intra-bolus pressure and esophagogastric gradient, assessed with high-resolution manometry, are associated with acid exposure and proximal migration of refluxate 18
Weak peristalsis with large breaks is associated with higher acid exposure and delayed reflux clearance in the supine position in GERD patients 17
Role of Mixed Reflux and Hypomotility with Delayed Reflux Clearance in Patients with Non-cardiac Chest Pain 17
Nutritional aspects in inflammatory bowel diseases 17
Role of Overweight and Obesity in Gastrointestinal Disease 16
Nutritional status and bioelectrical phase angle assessment in adult Crohn disease patients receiving anti-TNFα therapy 16
Adalimumab in active ulcerative colitis: A "real-life" observational study 16
Impedance-High Resolution Manometry Analysis of Patients With Nonerosive Reflux Disease 16
High-resolution Manometry Findings During Solid Swallows Correlate With Delayed Reflux Clearance and Acid Exposure Time in Non-erosive Reflux Disease Patients 16
Understanding the relationship between esophageal motor disorders and reflux disease 15
Reflux Patterns and Role of Impedance-pH Variables in Predicting PPI Response in Patients With Suspected GERD-Related Chronic Cough 15
Role of Esophageal Motility, Acid Reflux, and of Acid Suppression in Nonobstructive Dysphagia 15
Patients With Extra-Esophageal Symptoms, Compared to NERD Patients With Typical Symptoms and Healthy Volunteers, Arc Characterized by a Higher Number of Reflux Episodes and Higher Proportion of Weakly Acidic and Mixed Reflux 14
Increased frequency and enhanced perception of reflux in non-erosive reflux disease patients non-responder to proton pump inhibitors 13
REFLUX PATTERN AND ROLE OF IMPEDANCE-PH VARIABLES IN PREDICTING PPI RESPONSE IN PATIENTS WITH SUSPECTED GERD-RELATED CHRONIC COUGH 13
Therapeutic drug monitoring is more cost-effective than a clinically based approach in the management of loss of response to infliximab in inflammatory bowel disease: An observational multicentre study 12
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease 7
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care 6
Therapies for inflammatory bowel disease do not pose additional risks for adverse outcomes of SARS‐CoV‐2 infection: an IG‐IBD study 6
Ultrasonography Tight Control and Monitoring in Crohn’s Disease During Different Biological Therapies: A Multicenter Study 6
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey 5
Inflammatory bowel disease course in liver transplant versus non-liver transplant patients for primary sclerosing cholangitis: LIVIBD, an IG-IBD study 5
Real-life effectiveness and safety of tofacitinib and vedolizumab as 2nd-line for ulcerative colitis after anti-TNFs: A multicenter cohort IGIBD study (VE2TO-UC) 4
Vedolizumab in inflammatory bowel disease: Real-world outcomes and their prediction with machine learning—the IG-IBD LIVE study 4
Upadacitinib in Patients With Difficult-to-Treat Crohn’s Disease 3
IBD Flare in the COVID-19 Pandemic: Therapy Discontinuation Is to Blame 3
Comparison of two strategies for the management of postoperative recurrence in Crohn’s disease patients with one clinical risk factor: A multicentre IG‐IBD study 3
Effectiveness of ustekinumab in patients with refractory Crohn’s disease: a multicentre real-life study in Italy 3
Guselkumab in Patients With Moderately to Severely Active Ulcerative Colitis: QUASAR Phase 2b Induction Study 3
Effectiveness and safety of vedolizumab in a matched cohort of elderly and nonelderly patients with inflammatory bowel disease: the IG‐IBD LIVE study 3
Therapeutic adherence in inflammatory bowel disease: User guide from a multidisciplinary modified Delphi consensus 3
SARS-CoV-2 infection in patients with inflammatory bowel disease: comparison between the first and second pandemic waves 3
Totale 1.159
Salva come PNG Salva come JPEG
Categoria #
all - tutte 9.364
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 9.364
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202232 0 0 4 0 0 0 0 0 0 0 0 28
2022/202310 0 0 0 0 1 0 0 0 1 0 8 0
2023/202494 4 11 3 5 6 37 3 6 0 7 9 3
2024/20251.023 22 8 37 3 11 23 23 3 72 71 301 449
Totale 1.159